EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Stem cell therapies in the clinic

Shrinivas Acharya, Suyog Shaha, Michael Griffith Bibbey, Malini Mukherji, Zongmin Zhao iD, Samir Mitragotri

Bioengineering & Translational Medicine · 2025-05 · 10 (3)

DOI: 10.1002/btm2.70000 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Bioengineering & Translational Medicine, online erschienen am 04.02.2025. Verfasst von Shrinivas Acharya und 5 weiteren Autor:innen. Beteiligte Einrichtung: John A. Paulson School of Engineering and Applied Sciences Harvard University Massachusetts USA. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 163 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NHLBI NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Stem cell therapies have emerged as a transformative approach in modern medicine, with the potential to address and possibly cure a broad spectrum of diseases. These therapies utilize living stem cells that can perform complex biological functions not replicable by traditional drugs. Stem cell therapies have an expanding therapeutic landscape, with several products already approved and numerous clinical trials underway. Among the various stem cell types, hematopoietic stem cells (HSCs) and mesenchymal stem cells (MSCs) are most widely studied. In this review, we provide a detailed analysis of the current clinical landscape of stem cell therapies. We review 27 stem cell products that have received regulatory approvals and discuss 800 ongoing clinical trials, with a focus on HSCs and MSCs. We also discuss the critical challenges to be addressed to facilitate the clinical translation of stem cell therapies.

Schlagwörter

Stichwörter der Autor:innen

HSCMSCcellcell therapyclinical translationclinical trialsiPSCstem cell

Autor:innen und Institutionen

  • John A. Paulson School of Engineering and Applied Sciences Harvard University Massachusetts USA.
  • Wyss Institute for Biologically Inspired Engineering Harvard University Boston Massachusetts USA.
  • Department of Pharmaceutical Sciences, College of Pharmacy University of Illinois Chicago Chicago Illinois USA.

ORCID-Profile: Zongmin Zhao

Förderung

  • NCI NIH HHS
  • NHLBI NIH HHS
  • NIGMS NIH HHS
  • National Institutes of Health
  • Harvard School of Engineering and Applied Sciences

Zitieren

APA

Acharya, S., Shaha, S., Bibbey, M. G., Mukherji, M., Zhao, Z., & Mitragotri, S. (2025). Stem cell therapies in the clinic. Bioengineering & Translational Medicine, 10(3). https://doi.org/10.1002/btm2.70000

Vancouver

Acharya S, Shaha S, Bibbey MG, Mukherji M, Zhao Z, Mitragotri S. Stem cell therapies in the clinic. Bioengineering & Translational Medicine. 2025;10(3). doi:10.1002/btm2.70000

BibTeX
@article{Acharya2025,
  author = {Acharya, Shrinivas and Shaha, Suyog and Bibbey, Michael Griffith and Mukherji, Malini and Zhao, Zongmin and Mitragotri, Samir},
  title = {Stem cell therapies in the clinic},
  journal = {Bioengineering & Translational Medicine},
  year = {2025},
  volume = {10},
  number = {3},
  doi = {10.1002/btm2.70000}
}
Kostenlos starten →